Back to Trades
Giordano Christopher Thomas
CEODirectorCIK 0001871714
Profile
- Filings
- 4
- Buy transactions
- 5
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Giordano Christopher Thomas, CEO, Director, has filed 4 SEC reports (2025–2026), all concentrated in TENAX THERAPEUTICS, INC. (TENX), totaling $6.1M in disclosed volume. Weighing $40.1K bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $20.1K in TENAX THERAPEUTICS, INC.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Sep 15 | TENX TENAX THERAPEUTICS, INC. | Giordano Christopher Thomas | CEO, Director | Buy | $20.1K |
| Jul 14 | TENX TENAX THERAPEUTICS, INC. | Giordano Christopher Thomas | Insider | Exercise | $102.5K |
| Jan 13 | TENX TENAX THERAPEUTICS, INC. | Giordano Christopher Thomas | CEO, Director | Award | $6.0M |
| Nov 20 | TENX TENAX THERAPEUTICS, INC. | Giordano Christopher Thomas | CEO, Director | Buy | $20.0K |
4 filings